Cannabinoids

What Can The Cannabinoid Industry Learn From The US’s New Regulation On Synthetic Nicotine?

Many of the same fears are also being voiced for cannabinoid edibles

Are there lessons for the cannabinoid industry in the US federal government’s recent move to close the loophole that had kept synthetic nicotine out of US Food and Drug Administration (FDA) oversight?

Congress acted surprisingly quickly to clarify ambiguous legislation that had allowed vaping companies to continue to sell products without a premarket tobacco product application (PMTA) if they were made using synthetic nicotine, as this made them technically not tobacco-derived products.

Now, Washington DC law firm Patrick Malone & Associates has suggested that similar (relatively) rapid action could be taken at the federal level to clarify regulation of intoxicating cannabinoid edibles and that such a move could have a larger blowback for the industry, resulting in future prohibition or severe restrictions.

Many of the same fears that drove the change in regulation on synthetic nicotine and the related movement to prohibit or severely limit flavours in vaping products are also being voiced for cannabinoid edibles.

To Read The Rest Of This Article On CBD Health And Wellness, Click Here

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

  • Exotic Blvd
To Top